San Raffaele
San Raffaele
Italia, Milano
Francesco Montorsi
34 anni di esperienza
accreditamenti :
Clinica certificata da :
| Italia | Turchia | Austria | |
| Terapia radiante per il tumore renale | da $11,200 | da $6,500 | da $6,975 |
| Terapia con protoni | da $70,000 | da $70,000 | da $80,000 |
| Sistema robotico Da Vinci | da $18,000 | da $9,500 | da $22,000 |
| Radioterapia per il cancro colorettale | da $7,000 | da $7,000 | da $12,000 |
| Nefrectomia laparoscopica | da $15,000 | da $12,830 | da $15,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Tumore renale. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Tumore renale e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Tumore renale.
Il medico è un esperto leader in urologia e andrologia, dirigendo l'Istituto di Ricerca Urologica in Italia. Specializzandosi in chirurgia minimamente invasiva e robotica, il medico ha eseguito oltre 8.000 interventi di urologia e andrologia e ha sviluppato un metodo unico per correggere la disfunzione venosa occlusiva.<\/p>
Laureato all'Università di Milano, il medico ha una specializzazione in urologia e una borsa di studio onoraria dal Royal College of Surgeons of England. Con oltre 1.000 articoli pubblicati, il medico è riconosciuto come uno dei ricercatori più influenti dell'ultimo decennio.<\/p>
Il medico ha ricevuto numerosi premi, tra cui il Premio Hugh Hampton Young e il Premio alla Carriera Frans Debruyne.<\/p>
Il medico è il Direttore dell'Unità di Chirurgia Generale presso l'Ospedale Mater Olbia e possiede una Laurea in Medicina con Lode dall'Università Cattolica di Roma, Italia. Specializzandosi in chirurgia generale, il medico ha completato una residenza e ottenuto un Certificato di Specialista in Chirurgia Generale dalla stessa istituzione.<\/p>
Con un'esperienza vasta, il medico ha eseguito oltre 1300 procedure chirurgiche come primo operatore, inclusi trapianti di fegato, pancreas e rene, e più di 500 operazioni oncologiche, principalmente laparoscopiche, oltre a oltre 370 interventi di emergenza.<\/p>
Il medico ha anche contribuito al mondo accademico come insegnante di chirurgia generale ed è un membro attivo della Società Italiana di Chirurgia e della Società Italiana di Chirurgia Oncologica.<\/p>
Italy offers high-precision kidney cancer treatment at JCI-accredited and IRCCS-certified research hospitals. San Raffaele in Milan and Agostino Gemelli in Rome lead in surgical volume and innovation. These centers utilize da Vinci robotic systems and targeted immunotherapy to achieve high survival rates for renal tumors.
Bookimed Expert Insight: Data shows that San Raffaele performs over 52,000 operations annually. Choosing high-volume IRCCS centers in Milan or Rome ensures access to specific clinical trials. These research-focused institutions often provide newer immunotherapy drugs before they reach general hospitals.
Patient Consensus: Patients value the multidisciplinary approach where urologists and oncologists collaborate on one site. Many note that robotic surgery significantly shortened their hospital stay and reduced post-operative pain.
Italian centers offer advanced kidney cancer treatments including Da Vinci robotic surgery for partial nephrectomy. Patients access immunotherapy and targeted drugs like Pembrolizumab. Minimally invasive options like CyberKnife radiosurgery and cryotherapy are available inside JCI-accredited facilities. Specialized urology departments maintain kidney-sparing success rates up to 95% for localized tumors.
Bookimed Expert Insight: Italian urology excellence is driven by high-volume research hospitals like San Raffaele in Milan. This facility performs over 52,000 operations annually. Surgeons like Prof. Dr. Francesco Montorsi have completed over 8,000 urological surgeries. This vast experience level often leads to better preservation of healthy kidney tissue during complex tumor removals.
Italy is a safe and practical destination for kidney cancer surgery. It offers a 95% survival rate for nephrectomy procedures. Leading centers in Milan and Rome use three Da Vinci robotic systems. These facilities hold Joint Commission International and Newsweek rankings for oncology excellence.
Bookimed Expert Insight: Lombardy clinics like San Raffaele handle over 52,000 operations annually. This high volume correlates with advanced robotic proficiency. Data shows northern regions often provide quicker treatment pathways than southern areas. Patients seeking specific robotic expertise should focus on Milan-based centers for the most streamlined care.
Patient Consensus: Patients note that hiring a multilingual coordinator is vital as ward staff may have limited English. Those traveling from outside the EU emphasize planning for an extended stay of 14 days to prevent rushed discharges.
Verify Italian kidney cancer surgeons by checking the FNOMCeO national registry for a specialization in Urology or General Surgery. Prioritize surgeons at IRCCS-accredited research hospitals like San Raffaele in Milan. Ensure they hold international fellowships and have performed over 1,000 specialized procedures.
Bookimed Expert Insight: Italian surgical expertise is often concentrated in high-volume research hubs like Milan. Leading specialists such as Prof. Dr. Francesco Montorsi at San Raffaele have completed over 8,000 procedures. This volume is critical because data shows surgeons who operate on hundreds of patients annually maintain higher success rates with robotic and laparoscopic techniques than generalists.
Patient Consensus: Patients emphasize finding surgeons who are active members of the Italian Society of Urology. They note that personal communication about robotic surgery options is just as important as the surgeon's published research on PubMed.
Recovery after robotic kidney surgery in Italy typically lasts 4 to 8 weeks. Patients usually leave the hospital within 1 to 3 days. Most resume light desk work within 2 weeks. Full physical activity and heavy lifting are permitted after 4 to 6 weeks.
Bookimed Expert Insight: Italian research centers like San Raffaele specialize in ultra-minimally invasive protocols that eliminate bowel preparation. This allows patients to maintain a normal diet immediately after surgery. Data shows this approach often shortens the recovery period. Higher surgical volumes, such as the 8,000+ procedures performed by specialists like Dr. Francesco Montorsi, correlate with fewer complications and faster mobilization.
Patient Consensus: Patients note that light activity is possible early on. Many suggest stocking easy meals and using a walker for the first few days to aid movement.
Italian private hospitals offer online consultations for international patients before travel. Specialist networks and international patient departments provide video calls for second opinions. Private visits usually offer English-speaking doctors. Public institutions typically require in-person visits to initiate a formal treatment plan for oncology cases.
Bookimed Expert Insight: Italian medical centers like San Raffaele in Milan handle over 52,000 surgeries annually. High volumes at private IRCCS-accredited hospitals often mean faster access to robotic techniques. While some clinics require in-person visits, picking a hospital with a dedicated international department helps bypass local bureaucracy. This is vital when coordinating complex kidney cancer treatments like Da Vinci robotic surgery.
Patient Consensus: Patients note that public hospitals often prioritize locals and require physical presence. Seeking private specialists on digital platforms is faster for a quick initial opinion before flying.